Biolojic Design
Agent37Agent Readiness: 37/100. Below median. Measured by StartupHub.ai. Median 41.Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.
About
Biolojic Design is a biotechnology company that leverages an AI-driven computational platform to design developable, active human antibodies. Their technology focuses on targeting functional epitopes, including those considered difficult for existing antibody technologies, aiming to unlock new therapeutic possibilities for challenging diseases.
Key facts
At-a-glance profile data
- Website
- biolojic.com
- Headquarters
- Tel Aviv, Israel
- Founded
- 2010
- Employees
- 78
- Total funding
- $35M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 10 Jan 2023 | Seed | $10M | RA Capital |
| 1 Mar 2021 | Series A | $25M | aMoon |
Tech stack
Detected on biolojic.com, last scanned 24 Sept 2026. Run your own scan
- Compliance
- GDPR, CCPA
- Frontend
- jQuery
- Analytics
- Google Analytics 4
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- Email provider
- Microsoft 365
“Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma.”
View on Reddit“First AI-designed Antibody Enters Clinical Trials. "Biolojic Design will conduct the trial for cancer patients in Australia with a new type of drug that makes full use of computational biology and big data"”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.
Frequently asked
How much funding has Biolojic Design raised?
Biolojic Design has raised a total of $35M in funding. The most recent round on record is Seed.
How many employees does Biolojic Design have?
Biolojic Design has approximately 78 people on record.